US Patent No. 9,464,327

Recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma
Oct 12, 2016

The Chinese University of Hong Kong has been awarded US Patent No. 9,464,327, "Recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma."

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.